B. Riley Has Pessimistic Outlook of Celsius Q3 Earnings

Key Points

• B. Riley has reduced its Q3 2025 EPS estimates for Celsius from $0.23 to $0.22, while maintaining a "Buy" rating and a target price of $52.00.
• Several other brokerages, including JPMorgan and UBS, have raised their price targets for Celsius, indicating a strong consensus rating of "Moderate Buy" among analysts.
• Insider sales have been significant, with major shareholders selling hundreds of thousands of shares, even as Celsius' stock shows promising pricing with a current market cap of $12.23 billion.

Celsius Holdings Inc. (NASDAQ:CELH - Free Report) - Equities researchers at B. Riley cut their Q3 2025 earnings per share (EPS) estimates for Celsius in a report issued on Tuesday, July 29th. B. Riley analyst J. Van. Sinderen now forecasts that the company will post earnings of $0.22 per share for the quarter, down from their prior forecast of $0.23. B. Riley currently has a "Buy" rating and a $52.00 target price on the stock. The consensus estimate for Celsius' current full-year earnings is $0.89 per share.

A number of other equities research analysts also recently commented on CELH. Roth Capital restated a "buy" rating and issued a $52.00 target price (up previously from $46.00) on shares of Celsius in a research report on Thursday, June 26th. JPMorgan Chase & Co. lifted their target price on Celsius from $44.00 to $54.00 and gave the company an "overweight" rating in a research report on Thursday. Needham & Company LLC boosted their price objective on Celsius from $47.00 to $55.00 and gave the company a "buy" rating in a report on Thursday, July 10th. TD Cowen upgraded Celsius from a "hold" rating to a "buy" rating and boosted their price objective for the company from $37.00 to $55.00 in a report on Monday, June 16th. Finally, Citigroup assumed coverage on Celsius in a report on Wednesday, July 23rd. They issued a "buy" rating and a $55.00 price objective on the stock. One research analyst has rated the stock with a sell rating, four have issued a hold rating and fourteen have issued a buy rating to the company. According to MarketBeat.com, Celsius presently has a consensus rating of "Moderate Buy" and an average price target of $47.83.

Celsius Stock Down 1.4%

NASDAQ:CELH traded down $0.62 on Wednesday, reaching $44.72. The company's stock had a trading volume of 3,920,574 shares, compared to its average volume of 4,260,283. Celsius has a 12-month low of $21.10 and a 12-month high of $48.47. The firm has a market cap of $11.53 billion, a price-to-earnings ratio of 139.75, a price-to-earnings-growth ratio of 1.58 and a beta of 1.40. The stock has a 50 day moving average price of $43.50 and a 200 day moving average price of $35.45.

Celsius (NASDAQ:CELH - Get Free Report) last released its quarterly earnings data on Tuesday, May 6th. The company reported $0.18 earnings per share for the quarter, missing analysts' consensus estimates of $0.20 by ($0.02). The company had revenue of $329.28 million for the quarter, compared to analyst estimates of $349.09 million. Celsius had a return on equity of 42.12% and a net margin of 8.40%. The business's quarterly revenue was down 7.4% on a year-over-year basis. During the same period last year, the firm posted $0.27 EPS.

Insider Transactions at Celsius

In other news, major shareholder Deborah Desantis sold 100,000 shares of the company's stock in a transaction dated Monday, July 28th. The stock was sold at an average price of $47.00, for a total transaction of $4,700,000.00. Following the completion of the transaction, the insider directly owned 17,917,770 shares of the company's stock, valued at approximately $842,135,190. This represents a 0.56% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, major shareholder William H. Milmoe sold 300,000 shares of the company's stock in a transaction dated Tuesday, July 1st. The shares were sold at an average price of $47.27, for a total value of $14,181,000.00. Following the completion of the sale, the insider directly owned 18,017,770 shares of the company's stock, valued at approximately $851,699,987.90. This trade represents a 1.64% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 762,974 shares of company stock valued at $35,158,418. 2.55% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Celsius

A number of large investors have recently modified their holdings of CELH. Alliancebernstein L.P. increased its stake in Celsius by 26.3% in the 1st quarter. Alliancebernstein L.P. now owns 18,045,178 shares of the company's stock valued at $642,769,000 after purchasing an additional 3,753,055 shares in the last quarter. Vanguard Group Inc. increased its stake in Celsius by 2.2% in the 4th quarter. Vanguard Group Inc. now owns 15,813,110 shares of the company's stock valued at $416,517,000 after purchasing an additional 345,837 shares in the last quarter. Alyeska Investment Group L.P. increased its stake in Celsius by 60.5% in the 4th quarter. Alyeska Investment Group L.P. now owns 6,877,918 shares of the company's stock valued at $181,164,000 after purchasing an additional 2,591,345 shares in the last quarter. FMR LLC grew its holdings in Celsius by 64.2% during the 4th quarter. FMR LLC now owns 4,055,148 shares of the company's stock valued at $106,813,000 after buying an additional 1,585,839 shares during the last quarter. Finally, Champlain Investment Partners LLC acquired a new stake in Celsius during the 4th quarter valued at $85,068,000. 60.95% of the stock is owned by hedge funds and other institutional investors.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.